ARCHIVES

Bishop: Scientists Need Seat At NCI Executive Committee, More Voice In Decision Making

This article is from The Cancer Letter archive.

Vol. 21 No. 08 | February 24, 1995

Download PDF Visit The Full Archive

Related Articles

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011

Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer

August 30, 2013

In Brief: Six On NCA Serve Out Terms, No Successors in Sights DCBD Renamed With ‘Centers’ In Title

February 9, 1990

Adding Avastin Did Not Improve Standard Chemotherapy Regimen

April 27, 2012

Diet & Nutrition Wins Ok To Use Program Grants

February 20, 1976

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

April 27, 2001